- GMP
About
Nuvisan provides contract research and development services for drug discovery, preclinical development, clinical trials, and clinical trial supply. It serves pharmaceutical and biotech clients from sites in Germany, France, and India.
Services
Omics and biomarkers
Supports target identification and validation, mode-of-action studies, compound profiling, and pharmacodynamic and predictive biomarker discovery.
Assays & in vitro testing
Functional genomics and next-generation sequencing
Provides CRISPR/Cas9, RNA interference, NGS, single-cell sequencing, and bioinformatics for functional studies and target discovery.
Biosciences
Offers protein production, biochemical assays, cell-based assays, high-content analysis, biophysics, mass spectrometry, and structural biology support for hit identification and characterisation.
Assays & in vitro testing
Compound screening
Runs high-throughput screening to identify first hits against client-specific targets and mechanisms.
Assays & in vitro testing
Pharmacology
Delivers in vivo pharmacology models to generate efficacy and safety data for drug development.
Assays & in vitro testing
Chemistry
Supports hit-to-lead, lead optimisation, scale-up, biotransformations, and physicochemical characterisation.
Development DMPK
Provides in vitro and in vivo DMPK and ADME services, metabolite identification, isotope chemistry, and bioanalysis.
ADME, DMPK & toxicology
In vitro DMPK
Performs assays for metabolic stability, drug-drug interactions, metabolite identification, permeability and transporters, and protein binding.
ADME, DMPK & toxicology
Metabolite ID
Conducts cross-species metabolism and in vivo metabolite profiling and structure elucidation.
ADME, DMPK & toxicology
Preclinical development
Combines scale-up, formulation development, bioanalysis, DMPK, and toxicology testing to bridge discovery and clinical stages.
ADME, DMPK & toxicology
Clinical services phase 1-2
Provides phase 1 and 2 clinical trial services including clinical pharmacology, multicentre studies, medical and regulatory consulting, data management, biostatistics, and safety support.
Clinical pharmacology unit
Conducts early phase studies such as FIH, SAD/MAD, PoC, DDI, food effect, BA/BE, PK/PD, and special population studies.
Clinical laboratory
Performs clinical safety laboratory analyses using CE-certified tests and sample barcoding.
Assays & in vitro testing
Clinical trial supply services
Manages manufacturing, packaging, labelling, randomisation, analytical testing, logistics, storage, distribution, and QP release for clinical supplies.
Manufacturing of IMP
Develops and manufactures investigational medicinal products including capsules, powders, liquid formulations, and semi-solid formulations.
CDMO: development & manufacturing
Digital science technologies
Provides electronic lab notebook, LIMS, compound registration, assay data management, reporting, and data lifecycle tools.
Cheminformatics and machine learning
Develops predictive ML models, quantitative SAR models, and de novo generative chemistry tools for drug discovery.
Discovery services
Supports target understanding, target identification and validation, omics and biomarkers, biosciences, compound screening, pharmacology, chemistry, and discovery DMPK.
Assays & in vitro testing
Pharmaceutical analytical services
Provides analytical support for small and large molecules, including method development and validation, quality control, stability studies, EU re-testing, and commercial release.
Assays & in vitro testing
Drug substances
Supports drug substance development and related CMC work within integrated solutions.
Drug products
Supports drug product development and related CMC work within integrated solutions.
Bioanalysis
Provides bioanalytical support in preclinical and clinical development.
Assays & in vitro testing
Biomarkers
Provides biomarker services within discovery and clinical workflows.
Assays & in vitro testing
- What to send
- Sample barcoding
Capabilities
- Assays and studies
- Bioanalysis · Stability studies · CRISPR · ADME · Toxicology · In vivo · HTS · Small molecules · High-throughput screening · Biochemical assays · Cell-based assays · High-content assays
15 more
Biophysics assays · Protein binding assays · Drug-drug interaction assays · Metabolic stability assays · Permeability assays · Transporter assays · Metabolite identification · In vivo efficacy studies · PK/PD studies · Clinical safety lab analyses · Fragment screening · Virtual screening · Biophysical analyses · Structure-based design · CRISPR/Cas9 - Scale and capacity
- 40 high-monitoring beds · 60 overnight beds · Up to 100 L fermenters · 4-16 L wave bioreactors · Semi-solid clinical batches up to 50 kg · Proprietary small molecule library up to 3 million compounds · More than 5.000 m² GMP facilities · More than 320 m² of stability storage · Six full-time qualified persons
- Therapeutic areas
- Oncology · Dermatology
Instruments and platforms
- 10x Genomics
- ClinSpark
- ÄKTA
- SPR
- MST
- ITC
- NMR
- nanoDSF
- TSA
- SEC-MALS
- DLS
- F-SEC
- Flow cytometry
- MS
- HR-MS
- Electronic lab notebook
- LIMS
Modalities and species
- Modalities
- Small molecule · Antibody · ADC · Peptide · Gene editing · Recombinant protein · Vaccine · Biosimilar
- Species and models
- Rodent · Non-rodent species · Healthy volunteers · Special populations · Patients · iPSC-derived cells · Primary cells · Cell lines · E. coli · Insect cells · Mammalian cells · CHO
5 more
HEK293 · Expi293F · Tni · Tumour-bearing animal models · In vivo models
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
GLPSelf-reported
Scope: laboratories
Company
- Type
- CRDMO
- Team
- More than 100 analytical experts across Europe
Locations
- Address
- Wegenerstrasse 13 89231 Neu-Ulm Germany Berlin Muellerstrasse 178 13353 Berli
- Sites
- Neu-Ulm, Germany · Berlin, Germany · Sophia Antipolis, France · Grafing, Germany · Waltrop, Germany · Hyderabad, India
- Serves
- global, worldwide, Europe
Public records
Similar labs
Work here? Claim this listing